Back
Intellia Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
NTLA
Intellia Therapeutics, Inc.
Last Price:
$13.82
Seasonality Move:
0.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.74 | Sell |
| 20-day SMA: | 12.82 | Buy |
| 50-day SMA: | 11.98 | Buy |
| 200-day SMA: | 12.28 | Buy |
| 8-day EMA: | 13.78 | Sell |
| 20-day EMA: | 13.19 | Buy |
| 50-day EMA: | 12.51 | Buy |
| 200-day EMA: | 12.64 | Buy |
Intellia Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.54 | Buy |
| Relative Strength Index (14 RSI): | 53.75 | Buy |
| Chaikin Money Flow: | -8241627 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12 - 14) | Buy |
| Bollinger Bands (100): | (7.78 - 18.14) | Buy |
Intellia Therapeutics, Inc. Technical Analysis
| Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics, Inc. Stock
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 13.61 while NTLA 8-day simple moving average is 13.74, which is a Sell signal.
-
The stock price of NTLA is 13.61 while Intellia Therapeutics, Inc. 20-day SMA is 12.82, which makes it a Buy.
-
Intellia Therapeutics, Inc. 50-day simple moving average is 11.98 while NTLA share price is 13.61, making it a Buy technically.
-
NTLA stock price is 13.61 and Intellia Therapeutics, Inc. 200-day simple moving average is 12.28, creating a Buy signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
34
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Is Intellia Therapeutics, Inc. a Buy or a Sell?
-
Intellia Therapeutics, Inc. stock is rated a SellThe current Intellia Therapeutics, Inc. [NTLA] share price is $13.61. The Score for NTLA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
13.61
Share Volume:
8.3M
Intellia Therapeutics, Inc. 52-Week Range
52-Week High:
28.25
52-Week Low:
5.90
Sell
34
Intellia Therapeutics, Inc. (NTLA)
is a Sell
Intellia Therapeutics, Inc. Share Price Forecast
-
What is the Intellia Therapeutics, Inc. stock price today?The Intellia Therapeutics, Inc. stock price is 13.61 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics, Inc. is overvalued.
Is Intellia Therapeutics, Inc. Stock a Buy?
-
Intellia Therapeutics, Inc. share price is 13.61 while NTLA 8-day exponential moving average is 13.78, which is a Sell signal.
-
The stock price of NTLA is 13.61 while Intellia Therapeutics, Inc. 20-day EMA is 13.19, which makes it a Buy.
-
Intellia Therapeutics, Inc. 50-day exponential moving average is 12.51 while NTLA share price is 13.61, making it a Buy technically.
-
NTLA stock price is 13.61 and Intellia Therapeutics, Inc. 200-day simple moving average is 12.64, creating a Buy signal.
Fundamental Analysis of Intellia Therapeutics, Inc.
Is Intellia Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.42 per share, and an increase next year of $0.63 per share.
Technical Analysis of Intellia Therapeutics, Inc.
Should I short Intellia Therapeutics, Inc. stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 0.54, suggesting Intellia Therapeutics, Inc. is a Buy
-
Intellia Therapeutics, Inc. Relative Strength Index (RSI) is 53.75, which suggest Intellia Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics, Inc. is (12 - 14), which suggest Intellia Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Intellia Therapeutics, Inc. is (7.78 - 18.14), which suggest Intellia Therapeutics, Inc. is a Buy
* Intellia Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.